Abstract
Whether rifampin benefits retained staphylococcal prosthetic joint infection is unsettled. In a meta-analysis of 8 studies, we found greater clinical cure with fluoroquinolone-rifampin vs all other regimens (odds ratio [OR], 2.68; 95% CI, 1.43-5.02), but no greater cure with other rifampin combinations vs regimens without rifampin (OR, 1.22; 95% CI, 0.79-1.88).
Original language | English (US) |
---|---|
Article number | ofac582 |
Journal | Open Forum Infectious Diseases |
Volume | 9 |
Issue number | 12 |
DOIs | |
State | Published - Dec 1 2022 |
Keywords
- Prosthetic joint infection
- fluoroquinolone
- rifampin
- staphylococcus
ASJC Scopus subject areas
- Oncology
- Infectious Diseases